LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas
Open Access
- 1 November 1979
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 16 (5), 641-643
- https://doi.org/10.1128/aac.16.5.641
Abstract
One hundred eight clinical isolates of Proteus, Klebsiella, Serratia, and Pseudomonas spp. were tested in vitro against LY127935, cefamandole, cefoxitin, ticarcillin, carbenicillin, gentamicin, tobramycin, and amikacin by broth microdilution. The activities of LY127935 were greater than or equal to those of the other antimicrobial agents against Proteus vulgaris, Klebsiella pneumoniae, and Serratia marcescens. Inhibitions were greatest, however, for ticarcillin and carbenicillin versus Proteus morganii and gentamicin versus Pseudomonas aeruginosa.This publication has 7 references indexed in Scilit:
- Variation in response of Pseudomonas aeruginosa to combinations of gentamicin and carbenicillin.1979
- Comparison Between Agar and Broth Minimum Inhibitory Concentrations of Cefamandole, Cefoxitin, and CefuroximeAntimicrobial Agents and Chemotherapy, 1979
- Comparative In Vitro Activity of Newer Cephalosporins Against Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1978
- Comparison of In Vitro Antimicrobial Activity of Cefamandole and Cefazolin with Cephalothin Against over 8,000 Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 1976
- In Vitro Evaluation of Cefoxitin and CefamandoleAntimicrobial Agents and Chemotherapy, 1976
- Antibiotic susceptibility testing by a standardized single disk method.1966
- ANTIBIOTIC SUSCEPTIBILITY TESTING BY A STANDARDIZED SINGLE DISK METHOD1966